XML 49 R37.htm IDEA: XBRL DOCUMENT v3.4.0.3
Debt - Deerfield Facility Agreement (Details)
1 Months Ended 3 Months Ended 18 Months Ended
Apr. 01, 2016
USD ($)
Feb. 05, 2016
USD ($)
Jul. 10, 2015
USD ($)
Nov. 21, 2014
USD ($)
$ / shares
shares
Mar. 20, 2014
USD ($)
$ / shares
shares
Apr. 30, 2014
USD ($)
Mar. 31, 2014
USD ($)
Mar. 31, 2016
USD ($)
payment
shares
Mar. 31, 2015
USD ($)
Mar. 31, 2016
USD ($)
shares
Sep. 01, 2016
Dec. 31, 2015
USD ($)
Mar. 17, 2014
USD ($)
$ / shares
shares
Line of Credit Facility [Line Items]                          
Restricted cash               $ 1,250,000   $ 1,250,000   $ 2,350,000  
Common stock warrant liabilities               573,000   573,000   $ 687,000  
Deerfield [Member]                          
Line of Credit Facility [Line Items]                          
Maximum borrowing capacity                         $ 50,000,000
Transaction fee as percentage of principal amount                         2.50%
Line of credit       $ 6,000,000 $ 20,000,000     $ 26,200,000   26,200,000      
Net proceeds from initial draw under Facility Agreement         19,500,000                
Unamortized debt discount       200,000 500,000                
Net proceeds from draw under Facility Agreement       $ 5,900,000                  
Equal annual payments | payment               3          
Additional borrowings under the term loan     $ 5,000,000                    
Second Amendment with Deerfield [Member]                          
Line of Credit Facility [Line Items]                          
Debt instrument, stated interest rate   14.75%                     8.75%
Portion of interest paid-in-kind, percentage   6.00%                      
Amendment fee amount   $ 600,000                      
Amendment fee, installment amount   $ 200,000                      
Orthotec LLC, Litigation Settlement [Member]                          
Line of Credit Facility [Line Items]                          
Payments of settlement           $ 15,750,000 $ 1,750,000            
Orthotec LLC, Litigation Settlement [Member] | Deerfield [Member]                          
Line of Credit Facility [Line Items]                          
Payments of settlement                   $ 24,100,000      
Scenario, Forecast [Member] | Second Amendment with Deerfield [Member]                          
Line of Credit Facility [Line Items]                          
Portion of interest paid-in-kind, percentage                     3.00%    
Subsequent event [Member] | Orthotec LLC, Litigation Settlement [Member] | Deerfield [Member]                          
Line of Credit Facility [Line Items]                          
Payments of settlement $ 1,100,000                        
Initial and Draw Warrants [Member] | Deerfield [Member]                          
Line of Credit Facility [Line Items]                          
Warrants outstanding (in shares) | shares               11,450,000   11,450,000      
Gain (loss) from change in fair value of warrants               $ 100,000 $ (100,000)        
Initial Warrants [Member] | Deerfield [Member]                          
Line of Credit Facility [Line Items]                          
Number of securities called by warrants (in shares) | shares                         6,250,000
Exercise price of warrants (dollars per share) | $ / shares                         $ 1.39
Warrant amount reclassified as debt discount         $ 2,300,000     $ 200,000   $ 200,000      
Draw Warrants [Member] | Deerfield [Member]                          
Line of Credit Facility [Line Items]                          
Maximum borrowing capacity                         $ 50,000,000
Exercise price of warrants (dollars per share) | $ / shares       $ 1.39 $ 1.39                
Line of credit         $ 20,000,000                
Number of warrants issued (in shares) | shares       1,200,000 4,000,000                
Warrants value       $ 900,000 $ 4,700,000                
Draw Warrants [Member] | Maximum [Member] | Deerfield [Member]                          
Line of Credit Facility [Line Items]                          
Number of securities called by warrants associated with each disbursement borrowing (in shares) | shares                         10,000,000